跳至主要内容
临床试验/NCT03530046
NCT03530046已完成不适用

A Double-Blind, Randomized Control Trial of Rapidly Infused High Strong Ion Difference Fluid Versus Hartmann's Solution on Acid-Base Status in Sepsis and Septic Shock Patients in the Emergency Department Hospital Pulau Pinang

Clinical Research Centre, Malaysia0 个研究点目标入组 162 人开始时间: 2017年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
162
主要终点
pH change

研究概览

简要总结

This is a research to study primarily the effect of rapidly infused high strong ion difference (SID) fluid vs Hartmann's solution in altering the pH and bicarbonate level of the patient, who is in sepsis with metabolic acidosis. Half of the study population gets high SID fluid, while the other half will get Hartmann's solution.

详细描述

Balanced fluids are preferred in initial resuscitation of septic patients based on several recent studies.

The Stewart's concept on acid-base balance predicts that high strong ion difference (SID) fluid thus will increase the pH level.

High SID fluid are specially formulated by adding sodium bicarbonate into half saline solution, the resultant fluid contains sodium= 145mmol/L and chloride=70mmol/L (SID= 75) as compared to Hartmann's solution with the SID of 20.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age≥18 years
  • fulfills 2/3 qSOFA criteria
  • presumed infection
  • a blood pH at presentation ≤ 7.35
  • hyperlactatemia (blood lactate level, >2mmol/L )

排除标准

  • existing cardiac failure, major cardiac arrhythmia, advanced chronic kidney disease or end stage failure
  • known pregnancy
  • suspected dengue
  • primary diagnosis is related to burn, trauma, or drug overdose
  • if more than 500cc of resuscitation fluid was administered before enrollment.

研究组 & 干预措施

High SID fluid

Experimental

Group 1: half-normal saline with addition of 75mEq/L sodium bicarbonate

干预措施: High SID fluid (Combination Product)

Hartmann's solution

Active Comparator

Group 2: Hartmann's Solution

干预措施: Hartmann's solution (Combination Product)

结局指标

主要结局

pH change

时间窗: 2 hours

bicarbonate level change

时间窗: 2 hours

mmol/L

次要结局

  • Lactate level difference(2 hours)
  • Development of pulmonary edema(48 hours)
  • Length of stay(90 days)
  • 30 days all-cause mortality(30 days)

研究者

发起方
Clinical Research Centre, Malaysia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yeoh Chun Chiat

Principal Investigator

Clinical Research Centre, Malaysia

相似试验